- Home
- News
- us virgislands
- bone resorption
Bone Resorption Articles & Analysis
2 news found
Denosumab is an antibody treatment that shows a strong bone resorption inhibitory effect by targeting the RANKL protein, which is essential for the survival and function of osteoclasts. The original products are Amgen’s osteoporosis treatment Prolia (denosumab 60 mg), a treatment to prevent skeletal complications, and XGeva (denosumab 120 mg), a treatment ...
Several peptides have been shown to support and stimulate the bone healing response and have been proposed as therapeutic vehicles for clinical use. ...